ACTAVIS EXPANDS LOTUS LABS' FACILITIES IN B'LORE

The Iceland-headquartered Actavis Group announced the opening of the new premises of its subsidiary Lotus Labs in Bangalore recently. Actavis is the 5th largest generic drug-maker in the world in terms of revenue and the third largest on the number of employees. The new premises of Lotus Labs will house offices, laboratories and facilities for clinical bio-equivalence studies.

The Business Standard (http://www.business-standard.com/bsonline/storypage.php?bKeyFlag=BO&autono=14403)